Antinociceptive	antinociceptive	S_chemicals	O
and	and	O	O
antiamnesic	antiamnesic	O	O
properties	properties	O	O
of	of	O	O
the	the	O	O
presynaptic	presynaptic	S_chemicals	S_disease
cholinergic	cholinergic	S_chemicals	O
amplifier	amplifier	O	O
PG-9.The	pg-9.the	O	O
antinociceptive	antinociceptive	S_chemicals	O
effect	effect	O	O
of	of	O	O
3	3	O	O
alpha-tropyl	alpha-tropyl	O	O
2-(p-bromophenyl)propionate	2-(p-bromophenyl)propionate	O	O
[	[	O	O
(+/-)-PG-9	(+/-)-pg-9	O	O
]	]	O	O
(	(	O	O
10	10	O	O
-	-	O	O
40	40	O	O
mg	mg	O	O
kg-1	kg-1	O	O
s.c	s.c	O	O
.	.	O	O
;	;	O	O
30	30	O	O
-	-	O	O
60	60	O	O
mg	mg	O	O
kg-1	kg-1	O	O
p.o	p.o	O	O
.	.	O	O
;	;	O	O
10	10	O	O
-	-	O	O
30	30	O	O
mg	mg	O	O
kg-1	kg-1	O	O
i.v	i.v	O	O
.	.	O	O
;	;	O	O
10	10	O	O
-	-	O	O
30	30	O	O
micrograms/mouse	micrograms/mouse	O	O
i.c.v	i.c.v	O	O
.	.	O	O
)	)	O	O
was	was	O	O
examined	examined	O	O
in	in	O	O
mice	mice	O	O
,	,	O	O
rats	rats	O	O
and	and	O	O
guinea	guinea	O	O
pigs	pigs	O	O
by	by	O	O
use	use	O	O
of	of	O	O
the	the	O	O
hot-plate	hot-plate	O	O
,	,	O	O
abdominal-constriction	abdominal-constriction	O	O
,	,	O	O
tail-flick	tail-flick	O	O
and	and	O	O
paw-pressure	paw-pressure	O	O
tests	tests	O	O
.	.	O	O

(+/-)-PG-9	(+/-)-pg-9	O	O
antinociception	antinociception	O	O
peaked	peaked	O	O
15	15	O	O
min	min	O	O
after	after	O	O
injection	injection	O	O
and	and	O	O
then	then	O	O
slowly	slowly	O	O
diminished	diminished	O	O
.	.	O	O

The	the	O	O
antinociception	antinociception	O	O
produced	produced	O	O
by	by	O	O
(+/-)-PG-9	(+/-)-pg-9	O	O
was	was	O	O
prevented	prevented	O	O
by	by	O	O
the	the	O	O
unselective	unselective	O	O
muscarinic	muscarinic	B_chemicals	O
antagonist	antagonist	I_chemicals	O
atropine	atropine	O	O
,	,	O	O
the	the	O	O
M1-selective	m1-selective	O	O
antagonists	antagonists	O	O
pirenzepine	pirenzepine	S_chemicals	O
and	and	O	O
dicyclomine	dicyclomine	S_chemicals	O
and	and	O	O
the	the	O	O
acetylcholine	acetylcholine	S_chemicals	O
depletor	depletor	O	O
hemicholinium-3	hemicholinium-3	O	O
,	,	O	O
but	but	O	O
not	not	O	O
by	by	O	O
the	the	O	O
opioid	opioid	B_chemicals	S_disease
antagonist	antagonist	I_chemicals	O
naloxone	naloxone	O	O
,	,	O	O
the	the	O	O
gamma-aminobutyric	gamma-aminobutyric	S_chemicals	O
acidB	acidb	O	O
antagonist	antagonist	O	O
3-aminopropyl-diethoxy-methyl-phosphinic	3-aminopropyl-diethoxy-methyl-phosphinic	O	O
acid	acid	S_chemicals	O
,	,	O	O
the	the	O	O
H3	h3	B_chemicals	O
agonist	agonist	I_chemicals	O
R-(alpha)-methylhistamine	r-(alpha)-methylhistamine	O	O
,	,	O	O
the	the	O	O
D2	d2	B_chemicals	O
antagonist	antagonist	I_chemicals	O
quinpirole	quinpirole	O	O
,	,	O	O
the	the	O	O
5-hydroxytryptamine4	5-hydroxytryptamine4	O	O
antagonist	antagonist	O	O
2-methoxy-4-amino-5-chlorobenzoic	2-methoxy-4-amino-5-chlorobenzoic	O	O
acid	acid	S_chemicals	O
2-(diethylamino)ethyl	2-(diethylamino)ethyl	O	O
ester	ester	S_chemicals	O
hydrochloride	hydrochloride	O	O
,	,	O	O
the	the	O	O
5-hydroxytryptamin1A	5-hydroxytryptamin1a	O	O
antagonist	antagonist	O	O
1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine	1-(2-methoxyphenyl)-4-[4-(2-phthalimido)butyl]piperazine	O	O
hydrobromide	hydrobromide	S_chemicals	O
and	and	O	O
the	the	O	O
polyamines	polyamines	S_chemicals	O
depletor	depletor	O	O
reserpine	reserpine	O	O
.	.	O	O

Based	based	O	O
on	on	O	O
these	these	O	O
data	data	O	O
,	,	O	O
it	it	O	O
can	can	O	O
be	be	O	O
postulated	postulated	O	O
that	that	O	O
(+/-)-PG-9	(+/-)-pg-9	O	O
exerted	exerted	O	O
an	an	O	O
antinociceptive	antinociceptive	S_chemicals	O
effect	effect	O	O
mediated	mediated	O	O
by	by	O	O
a	a	O	O
central	central	O	O
potentiation	potentiation	O	O
of	of	O	O
cholinergic	cholinergic	S_chemicals	O
transmission	transmission	O	O
.	.	O	O

(+/-)-PG-9	(+/-)-pg-9	O	O
(	(	O	O
10	10	O	O
-	-	O	O
40	40	O	O
mg	mg	O	O
kg-1	kg-1	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
was	was	O	O
able	able	O	O
to	to	O	O
prevent	prevent	O	O
amnesia	amnesia	O	S_disease
induced	induced	O	O
by	by	O	O
scopolamine	scopolamine	S_chemicals	O
(	(	B_chemicals	O
1	1	I_chemicals	O
mg	mg	O	O
kg-1	kg-1	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
and	and	O	O
dicyclomine	dicyclomine	S_chemicals	O
(	(	B_chemicals	O
2	2	I_chemicals	O
mg	mg	O	O
kg-1	kg-1	O	O
i.p	i.p	O	O
.	.	O	O
)	)	O	O
in	in	O	O
the	the	O	O
mouse	mouse	O	O
passive-avoidance	passive-avoidance	O	O
test	test	O	O
.	.	O	O

Affinity	affinity	O	O
profiles	profiles	O	O
of	of	O	O
(+/-)-PG-9	(+/-)-pg-9	O	O
for	for	O	O
muscarinic	muscarinic	B_chemicals	O
receptor	receptor	I_chemicals	O
subtypes	subtypes	S_chemicals	O
,	,	O	O
determined	determined	O	O
by	by	O	O
functional	functional	O	O
studies	studies	O	O
(	(	O	O
rabbit	rabbit	O	O
vas	vas	O	O
deferens	deferens	O	O
for	for	O	O
M1	m1	O	O
,	,	O	O
guinea	guinea	O	O
pig	pig	O	O
atrium	atrium	O	O
for	for	O	O
M2	m2	O	O
,	,	O	O
guinea	guinea	O	O
pig	pig	O	O
ileum	ileum	O	O
for	for	O	O
M3	m3	O	O
and	and	O	O
immature	immature	O	O
guinea	guinea	O	O
pig	pig	O	O
uterus	uterus	O	O
for	for	O	O
putative	putative	O	O
M4	m4	S_chemicals	S_disease
)	)	O	O
,	,	O	O
have	have	O	O
shown	shown	O	O
an	an	O	O
M4/M1	m4/m1	O	O
selectivity	selectivity	O	O
ratio	ratio	O	O
of	of	O	O
10.2	10.2	O	O
that	that	O	O
might	might	O	O
be	be	O	O
responsible	responsible	O	O
for	for	O	O
the	the	O	O
antinociception	antinociception	O	O
and	and	O	O
the	the	O	O
anti-amnesic	anti-amnesic	O	O
effect	effect	O	O
induced	induced	O	O
by	by	O	O
(+/-)-PG-9	(+/-)-pg-9	O	O
through	through	O	O
an	an	O	O
increase	increase	O	O
in	in	O	O
acetylcholine	acetylcholine	S_chemicals	O
extracellular	extracellular	O	O
levels	levels	O	O
.	.	O	O

In	in	O	O
the	the	O	O
antinociceptive	antinociceptive	S_chemicals	O
and	and	O	O
antiamnesic	antiamnesic	O	O
dose	dose	O	O
range	range	O	O
,	,	O	O
(+/-)-PG-9	(+/-)-pg-9	O	O
did	did	O	O
not	not	O	O
impair	impair	O	O
mouse	mouse	O	O
performance	performance	O	O
evaluated	evaluated	O	O
by	by	O	O
the	the	O	O
rota-rod	rota-rod	O	O
test	test	O	O
and	and	O	O
Animex	animex	O	O
apparatus	apparatus	O	O
.	.	O	O

